ABOUT NOVACELL
A dedicated identity.
A clear foundation.
NovaCell Clinics LTD focuses on stem cells, with company-confirmed governance and facilities information presented transparently.
ABOUT NOVACELL
A clear identity.
Accountable leadership.
NovaCell Clinics LTD brings a dedicated stem cell focus to its next chapter.
The company’s clinic and laboratory remain at JCRC under a partnership and rental agreement. The facilities arrangement does not imply endorsement of every proposed intervention.
Company and board information below is supplied by NovaCell management and remains subject to documentary verification before launch.
BOARD OF DIRECTORS
PARTNERSHIP SETTING
Based at JCRC.
A separate company.
NovaCell operates as a separate company, with its clinic and laboratory based at JCRC under a premises partnership and rental arrangement.
A premises partnership and rental agreement does not establish regulatory authorization or endorsement of a particular clinical intervention. The draft does not attribute NovaCell’s proposed services or outcomes to JCRC.
Before public launch, the company identity, current governance, facilities agreement and applicable operational permissions require documentary verification.
BOARD & CLINICAL RESPONSIBILITY
Governance is not a clinical roster.
The company-confirmed board comprises Elly Karuhanga, Kristian Kvavik and Professor Alexzander A. A. Asea. The professor’s spelling is supported by the supplied source plan.
These are governance roles. Board membership does not establish who would assess an individual patient or deliver a clinical service. No additional qualifications, licenses, clinician appointments, biographies or staff photographs have been invented.
A verified clinical team directory should identify the responsible professionals, their roles and relevant current registration before a public clinical service is promoted. Until verified, the site makes no claim about a treating-team roster.